RESUMEN
In the absence of efficient alternative strategies, the control of parasitic nematodes, impacting human and animal health, mainly relies on the use of broad-spectrum anthelmintic compounds. Unfortunately, most of these drugs have a limited single-dose efficacy against infections caused by the whipworm, Trichuris. These infections are of both human and veterinary importance. However, in contrast to a wide range of parasitic nematode species, the narrow-spectrum anthelmintic oxantel has a high efficacy on Trichuris spp. Despite this knowledge, the molecular target(s) of oxantel within Trichuris is still unknown. In the distantly related pig roundworm, Ascaris suum, oxantel has a small, but significant effect on the recombinant homomeric Nicotine-sensitive ionotropic acetylcholine receptor (N-AChR) made up of five ACR-16 subunits. Therefore, we hypothesized that in whipworms, a putative homolog of an ACR-16 subunit, can form a functional oxantel-sensitive receptor. Using the pig whipworm T. suis as a model, we identified and cloned a novel ACR-16-like subunit and successfully expressed the corresponding homomeric channel in Xenopus laevis oocytes. Electrophysiological experiments revealed this receptor to have distinctive pharmacological properties with oxantel acting as a full agonist, hence we refer to the receptor as an O-AChR subtype. Pyrantel activated this novel O-AChR subtype moderately, whereas classic nicotinic agonists surprisingly resulted in only minor responses. We observed that the expression of the ACR-16-like subunit in the free-living nematode Caenorhabditis elegans conferred an increased sensitivity to oxantel of recombinant worms. We demonstrated that the novel Tsu-ACR-16-like receptor is indeed a target for oxantel, although other receptors may be involved. These finding brings new insight into the understanding of the high sensitivity of whipworms to oxantel, and highlights the importance of the discovery of additional distinct receptor subunit types within Trichuris that can be used as screening tools to evaluate the effect of new synthetic or natural anthelmintic compounds.
Asunto(s)
Antinematodos/farmacología , Proteínas del Helminto/antagonistas & inhibidores , Pirantel/análogos & derivados , Receptores Colinérgicos/química , Tricuriasis/tratamiento farmacológico , Trichuris/efectos de los fármacos , Animales , Caenorhabditis elegans/efectos de los fármacos , Femenino , Proteínas del Helminto/clasificación , Proteínas del Helminto/metabolismo , Masculino , Pirantel/farmacología , Receptores Colinérgicos/clasificación , Receptores Colinérgicos/metabolismo , Porcinos , Tricuriasis/metabolismo , Tricuriasis/parasitología , Xenopus laevis/metabolismoRESUMEN
The Drosophila melanogaster heart is a popular model in which to study cardiac physiology and development. Progress has been made in understanding the role of endogenous compounds in regulating cardiac function in this model. It is well characterized that common neurotransmitters act on many peripheral and non-neuronal tissues as they flow through the hemolymph of insects. Many of these neuromodulators, including acetylcholine (ACh), have been shown to act directly on the D. melanogaster larval heart. ACh is a primary neurotransmitter in the central nervous system (CNS) of vertebrates and at the neuromuscular junctions on skeletal and cardiac tissue. In insects, ACh is the primary excitatory neurotransmitter of sensory neurons and is also prominent in the CNS. A full understanding regarding the regulation of the Drosophila cardiac physiology by the cholinergic system remains poorly understood. Here we use semi-intact D. melanogaster larvae to study the pharmacological profile of cholinergic receptor subtypes, nicotinic acetylcholine receptors (nAChRs) and muscarinic acetylcholine receptors (mAChRs), in modulating heart rate (HR). Cholinergic receptor agonists, nicotine and muscarine both increase HR, while nAChR agonist clothianidin exhibits no significant effect when exposed to an open preparation at concentrations as low as 100 nM. In addition, both nAChR and mAChR antagonists increase HR as well but also display capabilities of blocking agonist actions. These results provide evidence that both of these receptor subtypes display functional significance in regulating the larval heart's pacemaker activity.
Asunto(s)
Drosophila melanogaster/fisiología , Frecuencia Cardíaca/efectos de los fármacos , Corazón/fisiología , Receptores Colinérgicos/metabolismo , Acetilcolina/administración & dosificación , Acetilcolina/farmacología , Animales , Agonistas Colinérgicos/administración & dosificación , Agonistas Colinérgicos/farmacología , Antagonistas Colinérgicos/administración & dosificación , Antagonistas Colinérgicos/farmacología , Proteínas de Drosophila/genética , Proteínas de Drosophila/metabolismo , Corazón/efectos de los fármacos , Larva/efectos de los fármacos , Larva/fisiología , Muscarina/administración & dosificación , Muscarina/farmacología , Nicotina/administración & dosificación , Nicotina/farmacología , Receptores Colinérgicos/clasificación , Receptores Colinérgicos/genéticaRESUMEN
Ca(2+) release from internal stores is critical for mediating both normal and pathological intracellular Ca(2+) signaling. Recent studies suggest that the inositol 1,4,5-triphosphate (IP(3)) receptor mediates Ca(2+) release from internal stores upon cholinergic activation of the neuromuscular junction (NMJ) in both physiological and pathological conditions. Here, we report that the type I IP(3) receptor (IP(3)R(1))-mediated Ca(2+) release plays a crucial role in synaptic gene expression, development, and neuromuscular transmission, as well as mediating degeneration during excessive cholinergic activation. We found that IP(3)R(1)-mediated Ca(2+) release plays a key role in early development of the NMJ, homeostatic regulation of neuromuscular transmission, and synaptic gene expression. Reducing IP(3)R(1)-mediated Ca(2+) release via siRNA knockdown or IP(3)R blockers in C2C12 cells decreased calpain activity and prevented agonist-induced acetylcholine receptor (AChR) cluster dispersal. In fully developed NMJ in adult muscle, IP(3)R(1) knockdown or blockade effectively increased synaptic strength at presynaptic and postsynaptic sites by increasing both quantal release and expression of AChR subunits and other NMJ-specific genes in a pattern resembling muscle denervation. Moreover, in two mouse models of cholinergic overactivity and NMJ Ca(2+) overload, anti-cholinesterase toxicity and the slow-channel myasthenic syndrome (SCS), IP(3)R(1) knockdown eliminated NMJ Ca(2+) overload, pathological activation of calpain and caspase proteases, and markers of DNA damage at subsynaptic nuclei, and improved both neuromuscular transmission and clinical measures of motor function. Thus, blockade or genetic silencing of muscle IP(3)R(1) may be an effective and well tolerated therapeutic strategy in SCS and other conditions of excitotoxicity or Ca(2+) overload.
Asunto(s)
Señalización del Calcio/fisiología , Receptores de Inositol 1,4,5-Trifosfato/fisiología , Músculo Esquelético/metabolismo , Síndromes Miasténicos Congénitos/patología , Unión Neuromuscular/fisiología , Síndromes de Neurotoxicidad/patología , Potenciales de Acción/efectos de los fármacos , Potenciales de Acción/genética , Animales , Compuestos de Boro/farmacología , Calcio/metabolismo , Señalización del Calcio/genética , Calpaína/metabolismo , Carbacol/farmacología , Caspasa 3/metabolismo , Caspasa 9/metabolismo , Línea Celular Transformada , Agonistas Colinérgicos/farmacología , Inhibidores de la Colinesterasa/toxicidad , Modelos Animales de Enfermedad , Electromiografía , Electroporación/métodos , Prueba de Esfuerzo , Regulación de la Expresión Génica/efectos de los fármacos , Regulación de la Expresión Génica/genética , Proteínas Fluorescentes Verdes/genética , Histona Desacetilasas/metabolismo , Histonas/genética , Histonas/metabolismo , Técnicas In Vitro , Receptores de Inositol 1,4,5-Trifosfato/deficiencia , Masculino , Potenciales de la Membrana/efectos de los fármacos , Potenciales de la Membrana/genética , Ratones , Ratones Transgénicos , Síndromes Miasténicos Congénitos/genética , Síndromes Miasténicos Congénitos/terapia , Neostigmina/toxicidad , Proteínas del Tejido Nervioso/metabolismo , Unión Neuromuscular/metabolismo , Síndromes de Neurotoxicidad/etiología , Síndromes de Neurotoxicidad/terapia , Técnicas de Placa-Clamp , ARN Interferente Pequeño/farmacología , Receptores Colinérgicos/clasificación , Receptores Colinérgicos/genética , Receptores Colinérgicos/metabolismo , Nervio Ciático/fisiopatología , Factores de TiempoRESUMEN
RATIONALE: The cholinergic system has long been linked to cognitive processes. Two main classes of acetylcholine (ACh) receptors exist in the human brain, namely muscarinic and nicotinic receptors, of which several subtypes occur. OBJECTIVES: This review seeks to provide an overview of previous findings on the influence of cholinergic receptor manipulations on cognition in animals and humans, with particular emphasis on the role of selected cholinergic receptor subtypes. Furthermore, the involvement of these receptor subtypes in the regulation of emotion and brain electrical activity as measured by electroencephalography (EEG) shall be addressed since these domains are considered to be important modulators of cognitive functioning. RESULTS: In regard to cognition, the muscarinic receptor subtypes have been implicated mainly in memory functions, but have also been linked to attentional processes. The nicotinic α7 receptor subtype is involved in working memory, whereas the α4ß2* subtype has been linked to tests of attention. Both muscarinic and nicotinic cholinergic mechanisms play a role in modulating brain electrical activity. Nicotinic receptors have been strongly associated with the modulation of depression and anxiety. CONCLUSIONS: Cholinergic receptor manipulations have an effect on cognition, emotion, and brain electrical activity as measured by EEG. Changes in cognition can result from direct cholinergic receptor manipulation or from cholinergically induced changes in vigilance or affective state.
Asunto(s)
Nivel de Alerta/fisiología , Encéfalo/metabolismo , Cognición/fisiología , Emociones/fisiología , Receptores Colinérgicos/fisiología , Animales , Electroencefalografía , Humanos , Aprendizaje/fisiología , Trastornos del Humor/metabolismo , Receptores Colinérgicos/clasificaciónRESUMEN
All current drugs approved to treat schizophrenia appear to exert their antipsychotic effects through blocking the dopamine D2 receptor. Recent meta-analyses and comparative efficacy studies indicate marginal differences in efficacy of newer atypical antipsychotics and the older drugs, and little effects on negative and cognitive symptoms. This review integrates findings from postmortem, imaging, and drug-challenge studies to elucidate a corticolimbic "pathologic circuit" in schizophrenia that may be particularly relevant to the negative symptoms and cognitive impairments of schizophrenia. Potential sites for pharmacologic intervention targeting glutatatergic, GABAergic, and cholinergic neurotransmission to treat these symptoms of schizophrenia are discussed.
Asunto(s)
Antipsicóticos/uso terapéutico , Neurotransmisores/uso terapéutico , Receptores Dopaminérgicos/metabolismo , Esquizofrenia/tratamiento farmacológico , Animales , Antipsicóticos/clasificación , Antipsicóticos/farmacología , Trastornos del Conocimiento/tratamiento farmacológico , Trastornos del Conocimiento/etiología , Humanos , Modelos Biológicos , Neurotransmisores/farmacología , Receptores Colinérgicos/clasificación , Receptores Colinérgicos/efectos de los fármacos , Receptores Colinérgicos/metabolismo , Receptores Dopaminérgicos/efectos de los fármacos , Receptores de GABA/efectos de los fármacos , Receptores de GABA/metabolismo , Receptores de N-Metil-D-Aspartato/clasificación , Receptores de N-Metil-D-Aspartato/efectos de los fármacos , Receptores de N-Metil-D-Aspartato/metabolismo , Esquizofrenia/complicacionesRESUMEN
PURPOSE OF RESEARCH: Although the pathogenesis of myasthenia gravis (MG) as an antibody mediated disorder of acetylcholine receptors (AChRs) at neuromuscular junctions is well understood, the origin of the autoimmune response is unclear. The thymus is intimately involved in initiation of the autoimmune response; the antigen, AChR, is present in the thymus, but how the autoimmune response is triggered is not known. Granzyme B (GrB), a proteolytic enzyme present in cytolytic T cells and natural killer (NK) cells, selectively cleaves many potential autoantigens (but few non-autoantigens), generating novel fragments that trigger autoreactive responses. This protease has been strongly implicated in the pathogenesis of several autoimmune diseases including lupus, rheumatoid arthritis, dermatomyositis, and others. In the studies described in this manuscript, we examined the ability of GrB to cleave the AChR subunits, and performed biochemical, immunohistochemical and molecular studies on thymus glands from myasthenic patients and controls to assess GrB expression. MAIN RESULTS: GrB efficiently and specifically cleaves subunits of AChR, especially the epsilon subunit. GrB is present in thymus glands from myasthenia patients, but is absent in control thymuses. CONCLUSIONS: Our results provide evidence supporting a potential role for GrB in the process of initiation of MG, and are consistent with the concept of an immunodominant epsilon epitope.
Asunto(s)
Granzimas/metabolismo , Granzimas/farmacología , Miastenia Gravis/patología , Timo/efectos de los fármacos , Timo/metabolismo , Autoinmunidad , Línea Celular , Expresión Génica/efectos de los fármacos , Expresión Génica/fisiología , Granzimas/genética , Humanos , Metionina/metabolismo , Receptores Colinérgicos/clasificación , Receptores Colinérgicos/genética , Receptores Colinérgicos/metabolismo , Receptores Nicotínicos , Isótopos de Azufre/metabolismo , TransfecciónRESUMEN
Synaptic plasticity underlies the adaptability of the mammalian brain, but has been difficult to study in living animals. Here we imaged the synapses between pre- and postganglionic neurons in the mouse submandibular ganglion in vivo, focusing on the mechanisms that maintain and regulate neurotransmitter receptor density at postsynaptic sites. Normally, synaptic receptor densities were maintained by rapid exchange of receptors with nonsynaptic regions (over minutes) and by continual turnover of cell surface receptors (over hours). However, after ganglion cell axons were crushed, synaptic receptors showed greater lateral mobility and there was a precipitous decline in insertion. These changes led to near-complete loss of synaptic receptors and synaptic depression. Disappearance of postsynaptic spines and presynaptic terminals followed this acute synaptic depression. Therefore, neurotransmitter receptor dynamism associated with rapid changes in synaptic efficacy precedes long-lasting structural changes in synaptic connectivity.
Asunto(s)
Neuronas/citología , Dinámicas no Lineales , Receptores Colinérgicos/metabolismo , Sinapsis/metabolismo , Análisis de Varianza , Animales , Axotomía/métodos , Bungarotoxinas/metabolismo , Potenciales Postsinápticos Excitadores/fisiología , Potenciales Postsinápticos Excitadores/efectos de la radiación , Regulación de la Expresión Génica/fisiología , Técnicas In Vitro , Péptidos y Proteínas de Señalización Intracelular/metabolismo , Proteínas Luminiscentes/metabolismo , Ratones , Ratones Transgénicos , Neuronas/metabolismo , Terminales Presinápticos/fisiología , Terminales Presinápticos/efectos de la radiación , Receptores Colinérgicos/clasificación , Receptores Colinérgicos/ultraestructura , Glándula Submandibular/citología , Factores de TiempoRESUMEN
The muscle nicotinic acetylcholine receptor (nAChR) is the major autoantigen in the autoimmune disease myasthenia gravis (MG), in which autoantibodies bind to, and cause loss of, nAChRs. Antibody-mediated nAChR loss is caused by the action of complement and by the acceleration of nAChR internalization caused by antibody-induced cross-linking of nAChR molecules (antigenic modulation). To obtain an insight into the role of the various anti-nAChR antibody specificities in MG, we have studied nAChR antigenic modulation caused by isolated anti-subunit autoantibodies. Autoantibodies against the nAChR alpha or beta subunits were isolated from four MG sera by affinity chromatography on columns carrying immobilized recombinant extracellular domains of human nAChR expressed in the yeast Pichia pastoris. The isolated anti-alpha and anti-beta autoantibodies, as well as untreated MG sera, induced nAChR antigenic modulation in TE671 cells. Partially antibody-depleted sera exhibited reduced modulating activity, whereas a serum completely depleted of anti-nAChR antibodies exhibited no nAChR modulation. Interestingly, the anti-alpha autoantibodies were, on average, approximately 4.3 times more effective than the anti-beta autoantibodies. The present work supports the notion that anti-nAChR autoantibodies may be the sole nAChR-reducing factor in anti-nAChR antibody-seropositive MG, and that anti-alpha-subunit autoantibodies are the dominant pathogenic autoantibody specificity.
Asunto(s)
Autoanticuerpos/aislamiento & purificación , Miastenia Gravis/sangre , Miastenia Gravis/inmunología , Receptores Colinérgicos/inmunología , Especificidad de Anticuerpos , Autoanticuerpos/análisis , Autoanticuerpos/inmunología , Autoantígenos/fisiología , Línea Celular Tumoral , Relación Dosis-Respuesta a Droga , Femenino , Regulación de la Expresión Génica/efectos de los fármacos , Humanos , Técnicas de Inmunoadsorción , Masculino , Subunidades de Proteína/inmunología , Receptores Colinérgicos/clasificación , Receptores Colinérgicos/deficiencia , Rabdomiosarcoma/patologíaRESUMEN
Pharmacological experiments on Ascaris suum have demonstrated the presence of three (N-, L-, and B-) subtypes of cholinergic receptor mediating contraction of body wall muscle in parasitic nematodes. In the present study, these ionotropic acetylcholine (ACh) receptors (nAChRs) were activated by levamisole and bephenium under patch-clamp conditions and competitively antagonized by paraherquamide and 2-desoxoparaherquamide. A number of recordings exhibited three separate current amplitude levels, indicating the presence of small, intermediate, and large conductance subtypes of receptor. The mean conductance of the small conductance subtype, G25, was 22 +/- 1 pS; the intermediate conductance channel, G35, was 33 +/- 1 pS; and the large conductance channel, G45, was 45 +/- 1 pS. The small channel was not antagonized significantly by paraherquamide and was identified as the N-subtype. The intermediate channel was preferentially activated by levamisole rather than bephenium and antagonized by paraherquamide: the intermediate channel was identified as the L-subtype. The large conductance channel was preferentially activated by bephenium, antagonized more by 2-desoxoparaherquamde than by paraherquamide and was identified as the B-subtype. These observations reveal that the three channel subtypes have different selectivity for cholinergic anthelmintics. The different selectivity of these compounds should be considered when dealing with drug resistant infections.
Asunto(s)
Antihelmínticos/farmacología , Ascaris suum/efectos de los fármacos , Ascaris suum/metabolismo , Receptores Colinérgicos/clasificación , Receptores Colinérgicos/metabolismo , Animales , Antihelmínticos/metabolismo , Compuestos de Befenio/farmacología , Relación Dosis-Respuesta a Droga , Indolizinas/farmacología , Levamisol/farmacología , Piridinas/farmacología , Compuestos de Espiro/farmacologíaRESUMEN
The mRNA isolated from mouse ocular and limb muscle and human rabdomyosarcoma cell line TE671 was subjected to reverse transcriptase polymerase chain reaction (RT-PCR) using a specific primer pair for the extracellular domain of AChR-alpha subunit that transcribes both for P3A- (isoform 1) and P3A+ (isoform 2). The cDNA synthesized from mRNA by reverse transcription, transcribed both isoforms 1 and 2 from mRNA of mouse limb and ocular muscle and human rabdomyosarcoma cell line TE671 as evidenced by agarose gel electrophoresis of polymerase chain reaction products.
Asunto(s)
ADN Complementario/genética , Músculo Esquelético/metabolismo , Receptores Colinérgicos/genética , Animales , Northern Blotting/métodos , Línea Celular Tumoral , Clonación Molecular/métodos , Ratones , Ratones Endogámicos C57BL , Datos de Secuencia Molecular , Miosarcoma , Isoformas de Proteínas/genética , Isoformas de Proteínas/metabolismo , ARN Mensajero/metabolismo , Receptores Colinérgicos/clasificación , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa/métodosRESUMEN
The receptors of amine subfamily are specifically major drug targets for therapy of nervous disorders and psychiatric diseases. The recognition of novel amine type of receptors and their cognate ligands is of paramount interest for pharmaceutical companies. In the past, Chou and co-workers have shown that different types of amine receptors are correlated with their amino acid composition and are predictable on its basis with considerable accuracy [Elrod and Chou (2002) Protein Eng., 15, 713-715]. This motivated us to develop a better method for the recognition of novel amine receptors and for their further classification. The method was developed on the basis of amino acid composition and dipeptide composition of proteins using support vector machine. The method was trained and tested on 167 proteins of amine subfamily of G-protein-coupled receptors (GPCRs). The method discriminated amine subfamily of GPCRs from globular proteins with Matthew's correlation coefficient of 0.98 and 0.99 using amino acid composition and dipeptide composition, respectively. In classifying different types of amine receptors using amino acid composition and dipeptide composition, the method achieved an accuracy of 89.8 and 96.4%, respectively. The performance of the method was evaluated using 5-fold cross-validation. The dipeptide composition based method predicted 67.6% of protein sequences with an accuracy of 100% with a reliability index > or =5. A web server GPCRsclass has been developed for predicting amine-binding receptors from its amino acid sequence [http://www.imtech.res.in/raghava/gpcrsclass/ and http://bioinformatics.uams.edu/raghava/gpersclass/ (mirror site)].
Asunto(s)
Receptores de Amina Biogénica/clasificación , Receptores Acoplados a Proteínas G/clasificación , Programas Informáticos , Inteligencia Artificial , Dipéptidos/química , Internet , Receptores Adrenérgicos/química , Receptores Adrenérgicos/clasificación , Receptores de Amina Biogénica/química , Receptores Colinérgicos/química , Receptores Colinérgicos/clasificación , Receptores Dopaminérgicos/química , Receptores Dopaminérgicos/clasificación , Receptores Acoplados a Proteínas G/química , Receptores de Serotonina/química , Receptores de Serotonina/clasificación , Análisis de Secuencia de ProteínaRESUMEN
Here we review recent studies on the mode of action of the cholinergic anthelmintics (levamisole, pyrantel etc.). We also include material from studies on the free living nematode Caenorhabditis elegans. The initial notion that these drugs act on a single receptor population, while attractive, has proven to be an oversimplification. In both free living and parasitic nematodes there are multiple types of nicotinic acetylcholine receptor (nAChR) on the somatic musculature. Each type has different (sometimes subtly so) pharmacological properties. The implications of these findings are: (1) combinations of anthelmintic that preferentially activate a broad range of nAChR types would be predicted to be more effective; (2) in resistant isolates of parasite where a subtype has been lost, other cholinergic anthelmintics may remain effective. Not only are there multiple types of nAChR, but relatively recent research has shown these receptors can be modulated; it is possible to increase the response of a parasite to a fixed concentration of drug by altering the receptor properties (e.g. phosphorylation state). These findings offer a potential means of increasing efficacy of existing compounds as an alternative to the costly and time consuming development of new anthelmintic agents.
Asunto(s)
Antinematodos/farmacología , Levamisol/farmacología , Nematodos/efectos de los fármacos , Nematodos/fisiología , Receptores de Neurotransmisores/efectos de los fármacos , Receptores de Neurotransmisores/metabolismo , Adenosina Trifosfato/metabolismo , Animales , Antinematodos/metabolismo , Caenorhabditis elegans/efectos de los fármacos , Caenorhabditis elegans/enzimología , Caenorhabditis elegans/fisiología , Proteínas Quinasas Dependientes de AMP Cíclico/metabolismo , Resistencia a Medicamentos/fisiología , Larva/fisiología , Levamisol/metabolismo , Potenciales de la Membrana/fisiología , Nematodos/enzimología , Nematodos/metabolismo , Neuropéptidos/efectos de los fármacos , Neuropéptidos/fisiología , Técnicas de Placa-Clamp/veterinaria , Monoéster Fosfórico Hidrolasas/metabolismo , Fosfotransferasas/metabolismo , Receptores Colinérgicos/química , Receptores Colinérgicos/clasificación , Receptores Colinérgicos/genética , Receptores Colinérgicos/metabolismoRESUMEN
Pontine and forebrain cholinergic nuclei contribute to the regulation of breathing and arousal. This report summarizes experiments in rat (n = 20) concerning the cholinergic interaction between pons and basal forebrain. In vitro [(35)S]guanylyl-5'-O-(gamma-thio)-triphosphate ([(35)S]GTPgammaS) autoradiography quantified carbachol-stimulated guanine nucleotide binding (G) protein activation in seven basal forebrain nuclei. Carbachol significantly increased [(35)S]GTPgammaS binding in the vertical and horizontal limbs of the diagonal band of Broca, medial and lateral septum, and nucleus basalis (B)/substantia innominata (SI). In vitro receptor autoradiography demonstrated muscarinic receptors in the same nuclei where carbachol caused G protein activation. In vivo experiments showed that carbachol administered to the pontine reticular formation (PnO) significantly decreased the number of 7-14Hz spindles in the electroencephalogram (EEG), decreased acetylcholine release in SI, and decreased respiratory rate. Carbachol microinjection into SI did not alter the number of EEG spindles or respiratory rate. The results help clarify that EEG and rate of breathing are more effectively modulated by cholinergic neurotransmission in PnO than in SI.
Asunto(s)
Acetilcolina/metabolismo , Puente/fisiología , Prosencéfalo/fisiología , Respiración , Sueño/fisiología , Animales , Autorradiografía/métodos , Sitios de Unión/efectos de los fármacos , Química Encefálica , Carbacol/farmacología , Agonistas Colinérgicos/farmacología , Electroencefalografía/métodos , Guanosina 5'-O-(3-Tiotrifosfato)/farmacocinética , Masculino , Microdiálisis/métodos , Microinyecciones/métodos , Puente/citología , Prosencéfalo/citología , Ratas , Ratas Sprague-Dawley , Receptores Colinérgicos/clasificación , Receptores Colinérgicos/metabolismo , Isótopos de Azufre/farmacocinéticaRESUMEN
BACKGROUND: From the deductive point of view, neurotransmitter receptors can be divided into categories such as cholinergic (muscarinic, nicotinic), adrenergic (alpha- and beta-), dopaminergic, serotoninergic (5-HT1 approximately 5-HT5), and histaminergic (H1 and H2). Selective agonists and antagonists of each receptor subtype can have specific useful therapeutic applications. For understanding the molecular mechanisms of action, an inductive method of analysis is useful. OBJECTIVE: The aim of the present study is to examine the structure-activity relationships of agents acting on G-protein coupled receptors. METHOD: Representative sets of G-PCR agonists and antagonists were identified from the literature and Medline [P.M. Walsh (2003) Physicians' Desk Reference; M.J. O'Neil (2001) The Merck Index]. The molecular weight (MW), calculated logarithm of octanol/water partition coefficient (C log P) and molar refraction (CMR), dipole moment (DM), E(lumo) (the energy of the lowest unoccupied molecular orbital, a measure of the electron affinity of a molecule and its reactivity as an electrophile), E(homo) (the energy of the highest occupied molecular orbital, related to the ionization potential of a molecule, and its reactivity as a nucleophile), and the total number of hydrogen bonds (H(b)) (donors and receptors), were chosen as molecular descriptors for SAR analyses. RESULTS: The data suggest that not only do neurotransmitters share common structural features but their receptors belong to the same ensemble of G-protein coupled receptor with seven to eight transmembrane domains with their resultant dipoles in an antiparallel configuration. Moreover, the analysis indicates that the receptor exists in a dynamic equilibrium between the closed state and the open state. The energy needed to open the closed state is provided by the hydrolysis of GTP. A composite 3-D parameter frame setting of all the neurotransmitter agonists and antagonists are presented using MW, Hb and mu as independent variables. CONCLUSION: It appears that all neurotransmitters examined in this study operate by a similar mechanism with the G-protein coupled receptors.
Asunto(s)
Neurotransmisores/antagonistas & inhibidores , Receptores Acoplados a Proteínas G/efectos de los fármacos , Receptores Acoplados a Proteínas G/fisiología , Relación Estructura-Actividad , Agonistas Adrenérgicos/química , Agonistas Adrenérgicos/clasificación , Antagonistas Adrenérgicos/química , Antagonistas Adrenérgicos/clasificación , Fenómenos Químicos , Química Física , Agonistas Colinérgicos/química , Agonistas Colinérgicos/clasificación , Antagonistas Colinérgicos/química , Antagonistas Colinérgicos/clasificación , Agonistas de Dopamina/química , Agonistas de Dopamina/clasificación , Agonistas de Dopamina/farmacología , Antagonistas de Dopamina/química , Antagonistas de Dopamina/clasificación , Antagonistas de Dopamina/farmacología , Agonistas de los Receptores Histamínicos/química , Agonistas de los Receptores Histamínicos/clasificación , Agonistas de los Receptores Histamínicos/farmacología , Antagonistas de los Receptores Histamínicos/química , Antagonistas de los Receptores Histamínicos/clasificación , Antagonistas de los Receptores Histamínicos/farmacología , Modelos Biológicos , Estructura Molecular , Neurotransmisores/agonistas , Neurotransmisores/química , Receptores Adrenérgicos/clasificación , Receptores Adrenérgicos/efectos de los fármacos , Receptores Adrenérgicos/fisiología , Receptores Colinérgicos/clasificación , Receptores Colinérgicos/efectos de los fármacos , Receptores Colinérgicos/fisiología , Receptores Histamínicos/clasificación , Receptores Histamínicos/efectos de los fármacos , Receptores Histamínicos/fisiología , Antagonistas de la Serotonina/química , Antagonistas de la Serotonina/clasificación , Antagonistas de la Serotonina/farmacología , Agonistas de Receptores de Serotonina/química , Agonistas de Receptores de Serotonina/clasificación , Agonistas de Receptores de Serotonina/farmacologíaRESUMEN
Binding and functional affinities of the muscarinic acetylcholine (mACh) receptor antagonists darifenacin, tolterodine, oxybutynin, and atropine were assessed in Chinese hamster ovary (CHO) cells expressing the human recombinant M2 (CHO-m2) or M3 (CHO-m3) receptors, and in guinea pig bladder and submandibular gland. In [N-methyl-3H]scopolamine methyl chloride binding studies in CHO cells, darifenacin displayed selectivity (14.8-fold) for the M3 versus M2 mACh receptor subtype. Oxybutynin was nonselective, whereas atropine and tolterodine were weakly M2-selective (5.1- and 6.6-fold, respectively). Antagonist functional affinity estimates were determined by the inhibition of agonist-induced [3H]inositol phosphate accumulation in CHO-m3 cells and antagonism of the agonist-induced inhibition of forskolin-stimulated cyclic AMP accumulation in CHO-m2 cells. Darifenacin was the most M3-selective antagonist (32.4-fold), whereas oxybutynin, atropine, and tolterodine exhibited lesser selectivity. Functional affinity estimates in guinea pig urinary bladder and submandibular salivary gland using indices of phosphoinositide turnover revealed that oxybutynin, darifenacin, and tolterodine each displayed selectivity for the response in the bladder, relative to that seen in the submandibular gland (9.3-, 7.9-, and 7.4-fold, respectively). In contrast, atropine displayed a similar affinity in both tissues. These data demonstrate that in bladder, compared with submandibular gland from a single species, the mACh receptor antagonists darifenacin, tolterodine, and oxybutynin display selectivity to inhibit agonist-mediated phosphoinositide responses. It is proposed that both responses are mediated via M3 mACh receptor activation and that differential functional affinities displayed by some, but not all, antagonists are indicative of the influence of cell background upon the pharmacology of the M3 mACh receptor.
Asunto(s)
Antagonistas Muscarínicos/farmacología , Fosfatidilinositoles/metabolismo , Receptor Muscarínico M3/metabolismo , Glándula Submandibular/metabolismo , Vejiga Urinaria/metabolismo , Animales , Células CHO , Antagonistas Colinérgicos/farmacología , Cricetinae , Femenino , Cobayas , Técnicas In Vitro , Ensayo de Unión Radioligante , Receptores Colinérgicos/clasificación , Receptores Colinérgicos/efectos de los fármacos , Receptores Colinérgicos/metabolismo , Glándulas Salivales/metabolismoRESUMEN
The serine hydrolases and proteases are a ubiquitous group of enzymes that is fundamental to many critical life-functions. Human tissues have two distinct cholinesterase activities: acetylcholinesterase and butyrylcholinesterase. Acetylcholinesterase functions in the transmission of nerve impulses, whereas the physiological function of butyrylcholinesterase remains unknown. Acetylcholinesterase is one of the crucial enzymes in the central and peripheral nerve system. Organophosphates and carbamates are potent inhibitors of serine hydrolases and well suited probes for investigating the chemical reaction mechanism of the inhibition. Understanding the enzyme's chemistry is essential in preventing and/or treating organophosphate and carbamate poisoning as well as designing new medicaments for cholinergic-related diseases like as Alzheimer's disease.
Asunto(s)
Acetilcolinesterasa/fisiología , Butirilcolinesterasa/fisiología , Neurotransmisores/fisiología , Sistema Nervioso Periférico/fisiología , Acetilcolinesterasa/química , Acetilcolinesterasa/metabolismo , Envejecimiento/fisiología , Enfermedad de Alzheimer/metabolismo , Enfermedad de Alzheimer/fisiopatología , Animales , Butirilcolinesterasa/química , Butirilcolinesterasa/metabolismo , Humanos , Receptores Colinérgicos/clasificación , Receptores Colinérgicos/fisiologíaRESUMEN
A delayed-matching spatial working memory protocol in a 5-arm maze was used to test the hypothesis of differential roles for central nicotinic and muscarinic cholinergic receptors in mediating task performance. In experiment 1, using a within subjects-repeated design, groups of C57Bl/6 mice, previously trained to criterion with a 4 h retention interval separating presentation and test phases, received i.p. injections of either saline, scopolamine (0.8 mg/kg), mecamylamine (8.0 mg/kg), or the combination of scopolamine and mecamylamine before re-testing. Injections were given either, a) 15 min pre-presentation or, b) 30 s, c) 15 min, d) 3 h 45 min post-presentation in order to differentially affect the acquisition, trace maintenance and recall phases. Significant decreases in correct responses were observed for each drug treatment but the effects were a function of the time of treatment. Results of condition d), (i.e.15 min before retention test) confirm previous reports of severe disruption by each antagonist and their combination on retention. However, conditions a-c) show a constant disruption by scopolamine, increasing disruption by mecamylamine, whereas the combined treatment was without effect. Although the data show that central nicotinic and muscarinic antagonists both modulate working memory performance, they indicate first, that scopolamine-induced "amnesia" results, not from selective post-synaptic M1 muscarinic blockade but from indirect over-activation of nicotinic receptors. Second, the observation of high levels of retention although nicotinic and muscarinic receptors had undergone combined blockade during a large part of the retention interval is incompatible with the concept that test-induced activation of central cholinergic neurones mediates memory trace maintenance. Finally, taken with data from experiment 2, using a short (20 min) treatment-to-test interval, we conclude that central nicotinic receptors play a key role in attentional processes enabling working memory trace access during retrieval.
Asunto(s)
Sistema Nervioso Central/fisiología , Aprendizaje por Laberinto/fisiología , Memoria a Corto Plazo/fisiología , Receptores Colinérgicos/fisiología , Conducta Espacial/fisiología , Animales , Conducta Animal/efectos de los fármacos , Sistema Nervioso Central/efectos de los fármacos , Interacciones Farmacológicas , Masculino , Aprendizaje por Laberinto/efectos de los fármacos , Mecamilamina/farmacología , Memoria a Corto Plazo/efectos de los fármacos , Ratones , Ratones Endogámicos C57BL , Antagonistas Muscarínicos/farmacología , Antagonistas Nicotínicos/farmacología , Tiempo de Reacción/efectos de los fármacos , Receptores Colinérgicos/clasificación , Retención en Psicología/efectos de los fármacos , Retención en Psicología/fisiología , Escopolamina/farmacología , Conducta Espacial/efectos de los fármacos , Factores de TiempoRESUMEN
Cell-specific expression of nicotinic acetylcholine receptors (AChRs) was examined using ciliary and choroid neurons isolated from chick ciliary ganglia. At embryonic days 13 and 14 (E13,14) the neurons can be distinguished by size, with ciliary neuron soma diameters exceeding those of choroid neurons by about twofold. Both neuronal populations are known to express two major AChR types: alpha3*-AChRs recognized by mAb35, that contain alpha3, alpha5, beta4, and occasionally beta2 subunits, and alpha-bungarotoxin (alphaBgt)-AChRs recognized and blocked by alphaBgt, that contain alpha7 subunits. We found that maximal whole cell current densities (I/C(m)) mediated by alphaBgt-AChRs were threefold larger for choroid compared with ciliary neurons, while alpha3*-AChR current densities were similar in the two populations. Different densities of total cell-surface alphaBgt-AChRs could not explain the distinct alphaBgt-AChR response densities associated with ciliary and choroid neurons. Ciliary ganglion neurons display abundant [(125)I]-alphaBgt binding ( approximately 10(6) sites/neuron), but digital fluorescence measurements revealed equivalent site densities on both populations. AChR channel classes having single-channel conductances of approximately 30, 40, 60, and 80 pS were present in patches excised from both ciliary and choroid neurons. Treating the neurons with alphaBgt selectively abolished the 60- and 80-pS events, identifying them as arising from alphaBgt-AChRs. Kinetic measurements revealed brief open and long closed durations for alphaBgt-AChR channel currents, predicting a very low probability of being open (p(o)) when compared with 30- or 40-pS alpha3*-AChR channels. None of the channel parameters associated with the 60- and 80-pS alphaBgt-AChRs differed detectably, however, between choroid and ciliary neurons. Instead calculations based on the combined whole cell and single-channel results indicate that choroid neurons express approximately threefold larger numbers of functional alphaBgt-AChRs (N(F)) per unit area than do ciliary neurons. Comparison with total surface [(125)I]-alphaBgt-AChR sites (N(T)), reveals that N(F)/N(T) << 1 for both neuron populations, suggesting that "silent" alphaBgt-AChRs predominate. Choroid neurons may therefore express a higher density of functional alphaBgt-AChRs by recruiting a larger fraction of receptors from the silent pool than do ciliary neurons.
Asunto(s)
Bungarotoxinas/farmacología , Coroides/inervación , Cuerpo Ciliar/inervación , Ganglios Parasimpáticos/metabolismo , Neuronas/metabolismo , Receptores Colinérgicos/metabolismo , Animales , Anticuerpos Monoclonales/farmacología , Axones/metabolismo , Sitios de Unión/efectos de los fármacos , Tamaño de la Célula/fisiología , Células Cultivadas , Embrión de Pollo , Relación Dosis-Respuesta a Droga , Colorantes Fluorescentes , Ganglios Parasimpáticos/citología , Canales Iónicos/metabolismo , Neuronas/clasificación , Neuronas/citología , Nicotina/farmacología , Agonistas Nicotínicos/farmacología , Técnicas de Placa-Clamp , Tiempo de Reacción/efectos de los fármacos , Receptores de Superficie Celular , Receptores Colinérgicos/clasificación , Receptores Colinérgicos/efectos de los fármacosRESUMEN
Nicotinic agonists elicit the release of dopamine from striatal synaptosomes by acting on presynaptic nicotinic acetylcholine receptors (nAChRs) on dopamine nerve terminals. Both alpha3beta2* and alpha4beta2 nAChR subtypes (but not alpha7* nAChRs) have been implicated. Here, we compared nAChR-evoked [(3)H]dopamine release from rat striatal synaptosome and slice preparations by using the nicotinic agonist anatoxin-a. In the more integral slice preparation, the concentration-response curve for anatoxin-a-evoked [(3)H]dopamine release was best fitted to a two-site model, giving EC(50) values of 241 nM and 5.1 microM, whereas only the higher-affinity component was observed in synaptosome preparations (EC(50) = 134 nM). Responses to a high concentration of anatoxin-a (25 microM) in slices (but not in synaptosomes) were partially blocked by ionotropic glutamate receptor antagonists (kynurenic acid, 6,7-dinitroquinoxaline-2,3-dione) and by alpha7*-selective nAChR antagonists (alpha-bungarotoxin, alpha-conotoxin-ImI, methyllycaconitine) in a nonadditive manner. In contrast, the alpha3beta2-selective nAChR antagonist alpha-conotoxin-MII partially inhibited [(3)H]dopamine release from both slice and synaptosome preparations, stimulated with both low (1 microM) and high (25 microM) concentrations of anatoxin-a. Antagonism by alpha-conotoxin-MII was additive with that of alpha7*-selective antagonists. These data support a model in which alpha7* nAChRs on striatal glutamate terminals elicit glutamate release, which in turn acts at ionotropic glutamate receptors on dopamine terminals to stimulate dopamine release. In addition, non-alpha7* nAChRs on dopamine terminals also stimulate dopamine release. These observations have implications for the complex cholinergic modulation of inputs onto the major efferent neurons of the striatum.
Asunto(s)
Bungarotoxinas/farmacología , Cuerpo Estriado/metabolismo , Dopamina/metabolismo , Ácido Glutámico/metabolismo , Receptores Nicotínicos/metabolismo , Animales , Cuerpo Estriado/efectos de los fármacos , Antagonistas de Aminoácidos Excitadores/farmacología , Técnicas In Vitro , Masculino , Neurotransmisores/fisiología , Ratas , Ratas Sprague-Dawley , Receptores Colinérgicos/clasificación , Receptores Dopaminérgicos/metabolismo , Receptores de Glutamato/metabolismo , Receptores Nicotínicos/efectos de los fármacos , Receptores Presinapticos/clasificación , TritioRESUMEN
The aim of this study was to characterize the pharmacology of presynaptic nicotinic cholinoceptors (nAChRs) that modulate release of 5-hydroxytryptamine (5-HT) from superfused rat brain synaptosomes preloaded with [3H]5-HT. Nicotine increased 5-HT release from striatal synaptosomes (maximally by 15-30%) but not from cerebral cortex or hippocampal synaptosomes. Release of striatal 5-HT was increased in a concentration-dependent manner by nicotine, epibatidine, cytisine, and ACh (with added esterase inhibitor and muscarinic antagonist). Respective EC50 values were: 0.5, 0.003, 0.1 and 0.7 microM. The maximal effect of each agonist was virtually completely blocked by a high concentration of the insurmountable nicotinic antagonist mecamylamine; at a higher concentration of epibatidine (3 microM), a mecamylamine-insensitive effect was revealed. Nicotine, ACh and epibatidine appeared equally efficacious, whereas cytisine was of lower efficacy (60-70% of ACh). Release evoked by a half-maximal concentration of nicotine was inhibited by the nicotinic antagonists dihydro-beta-erythroidine (IC50 0.04 microM) and methyllycaconitine (IC50 0.06 microM). Nicotine-evoked 5-HT release was not reduced by tetrodotoxin given in a concentration that blocked veratridine-evoked release. These findings provide functional evidence for a direct action of nicotine on 5-HT neurons in the brain. The presynaptic nAChRs that modulate striatal 5-HT release appear to possess a novel pharmacological profile.